Cocaine hydrochloride
HealthData.Gov
Updated Oct 29, 2026
About this dataset
GOPRELTO is a prescription nasal solution containing 4% cocaine hydrochloride (equivalent to 40 mg/mL). It is a DEA Schedule II controlled substance, manufactured by LXO US INC., and approved under NDA209963 for medical use. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Cocaine hydrochloride
Access the FDA dataset for Cocaine hydrochloride — ANDA 209575 submitted by Mylan Institutional LLC
Modified Apr 29, 2026